Oxford Nanopore Technologies plc (Oxford Nanopore) and PathoQuest today announce the agreement of a MOU for a collaboration to commercialise a transfo ...

Alexandre Mérieux, bioMérieux Chairman and CEO, commented: “We are excited to enter into a research partnership with Oxford Nanopore in the field of infectious diseases.

Nanopore sequencing provides researchers with many advantages for whole-genome sequencing, including: Easier assembly – long sequencing reads mean fewer fragments to assemble ...

Nanopore sensors can identify a wide variety of single molecules and biomolecules, but all such devices made so far rely on electrodes to measure the current change through the nanopore as a molecule ...

After closing three separate funding rounds throughout 2020 that, all together, totaled more than $300 million, Oxford Nanopore Technologies is well on track to make 2021 even bigger. Just a few ...

Oxford Nanopore Technologies has signed a partnership with artificial intelligence developer SeqOne to support its next-generation sequencing approach in clinical diagnostic testing. The goal will ...

A British company announced plans to market the first commercial DNA sequencer using nanopore technology pioneered at UCSC.

Oxford Nanopore, a provider of rapid COVID-19 tests to Britain's national health service, announced a London listing on Thursday as it aims to build on the 2.4 billion pound ($3.3 billion ...

Researchers present a special silicon nitride nanopore-based sensing device that is designed to provide volume information about tau and tubulin protein molecules and their aggregation states. To ...

With the rapid advancement of genomic technologies, it is now possible to characterize pathogens more easily and comprehensively than ever before. However, there are many limitations associated with ...